{"id":"https://openalex.org/W2000972014","doi":"https://doi.org/10.1007/s00280-009-1023-8","title":"Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-\u03b15\u03b21 integrin monoclonal antibody (volociximab) in cancer patients","display_name":"Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-\u03b15\u03b21 integrin monoclonal antibody (volociximab) in cancer patients","alternate_titles":[],"publication_year":2009,"publication_date":"2009-05-25","ids":{"openalex":"https://openalex.org/W2000972014","doi":"https://doi.org/10.1007/s00280-009-1023-8","mag":"2000972014","pmid":"https://pubmed.ncbi.nlm.nih.gov/19468731"},"language":"en","primary_location":{"id":"doi:10.1007/s00280-009-1023-8","doi":"https://doi.org/10.1007/s00280-009-1023-8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-009-1023-8","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000972014"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000728724","display_name":"Chee M. Ng","orcid":"https://orcid.org/0000-0002-9452-7748","observed_orcids":["https://orcid.org/0000-0002-9452-7748","https://orcid.org/0000-0001-6053-9196"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Chee M. Ng","raw_affiliation_strings":["Cancer Therapy and Research Center, Institute for Drug Development, The University of Texas Health Science Center at San Antonio, San Antonio, 78229, USA. ng.cheem@yahoo.com","The University of Texas Health Science Center at San Antonio,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Therapy and Research Center, Institute for Drug Development, The University of Texas Health Science Center at San Antonio, San Antonio, 78229, USA. ng.cheem@yahoo.com","institution_ids":["https://openalex.org/I165951966"]},{"raw_affiliation_string":"The University of Texas Health Science Center at San Antonio,","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068949418","display_name":"Shuang Bai","orcid":"https://orcid.org/0000-0001-6404-7703","observed_orcids":["https://orcid.org/0000-0001-6404-7703"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Bai","raw_affiliation_strings":["Genentech, South San Francisco, CA, USA","GENENTECH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"GENENTECH","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045286901","display_name":"Chris H.M. Takimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. H. Takimoto","raw_affiliation_strings":["South Texas Accelerated Research Therapeutics (START), San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South Texas Accelerated Research Therapeutics (START), San Antonio, TX, USA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046819247","display_name":"Meina Tao Tang","orcid":"https://orcid.org/0000-0002-4787-742X","observed_orcids":["https://orcid.org/0000-0002-4787-742X"]},"institutions":[{"id":"https://openalex.org/I4405280693","display_name":"AbbVie Biotherapeutics (United States)","ror":"https://ror.org/03a0g6939","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688","https://openalex.org/I4405280693"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. T. Tang","raw_affiliation_strings":["Facet Biotech, Corp, Redwood City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facet Biotech, Corp, Redwood City, CA, USA","institution_ids":["https://openalex.org/I4405280693"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060992997","display_name":"Anthony W. Tolcher","orcid":"https://orcid.org/0000-0002-6322-9721","observed_orcids":["https://orcid.org/0000-0002-6322-9721"]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. W. Tolcher","raw_affiliation_strings":["South Texas Accelerated Research Therapeutics (START), San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South Texas Accelerated Research Therapeutics (START), San Antonio, TX, USA","institution_ids":["https://openalex.org/I4210119066"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5000728724"],"corresponding_institution_ids":["https://openalex.org/I165951966"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":1.3781,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.79995793,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"65","issue":"2","first_page":"207","last_page":"217"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.4147999882698059,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.4147999882698059,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.39309999346733093,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.04089999943971634,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8949999809265137},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7900000214576721},{"id":"https://openalex.org/keywords/dose-simulation","display_name":"dose simulation","score":0.40299999713897705},{"id":"https://openalex.org/keywords/binding-saturation","display_name":"binding saturation","score":0.7739999890327454},{"id":"https://openalex.org/keywords/monte-carlo-simulation","display_name":"Monte Carlo simulation","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6498501300811768},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6424031257629395},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5741336345672607},{"id":"https://openalex.org/C195687474","wikidata":"https://www.wikidata.org/wiki/Q409715","display_name":"Integrin","level":3,"score":0.5582594871520996},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5492838621139526},{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.5254522562026978},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49434757232666016},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44243699312210083},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4400622248649597},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4226028323173523},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3753680884838104},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37435638904571533},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31287479400634766},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3007500171661377},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2942937910556793},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D039081","descriptor_name":"Integrin alpha5beta1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D039081","descriptor_name":"Integrin alpha5beta1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s00280-009-1023-8","doi":"https://doi.org/10.1007/s00280-009-1023-8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-009-1023-8","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:19468731","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19468731","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W2556336","https://openalex.org/W105671925","https://openalex.org/W152943885","https://openalex.org/W1533841403","https://openalex.org/W1679229092","https://openalex.org/W1998709931","https://openalex.org/W1999759354","https://openalex.org/W2000000541","https://openalex.org/W2000292756","https://openalex.org/W2001753204","https://openalex.org/W2002973809","https://openalex.org/W2008751117","https://openalex.org/W2018159680","https://openalex.org/W2026184890","https://openalex.org/W2029773366","https://openalex.org/W2038413195","https://openalex.org/W2039103439","https://openalex.org/W2070134611","https://openalex.org/W2076171495","https://openalex.org/W2082535104","https://openalex.org/W2086619383","https://openalex.org/W2114112168","https://openalex.org/W2188422153","https://openalex.org/W2261592159","https://openalex.org/W2397477141","https://openalex.org/W2597686203","https://openalex.org/W2916501267","https://openalex.org/W2965751775","https://openalex.org/W3017302833","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2026184890","https://openalex.org/W2066351358","https://openalex.org/W4414575410","https://openalex.org/W1987756147","https://openalex.org/W1679089852","https://openalex.org/W2590834357","https://openalex.org/W7131276251","https://openalex.org/W2768877681","https://openalex.org/W4210928292","https://openalex.org/W3213740961"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000972014","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
